Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells
Intrachromosomal Amplification of Chromosome 21
Masonic Cancer Center, University of MinnesotaCell therapyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Intrachromosomal Amplification of Chromosome 21 cohort.
Same molecule, other indications
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →